168 related articles for article (PubMed ID: 30651861)
1. Comparative evaluation of the osteogenic capacity of human mesenchymal stem cells from bone marrow and umbilical cord tissue.
Wang Q; Zhao G; Xing Z; Zhan J; Ma J
Exp Ther Med; 2019 Jan; 17(1):764-772. PubMed ID: 30651861
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord Wharton's Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering.
Hou T; Xu J; Wu X; Xie Z; Luo F; Zhang Z; Zeng L
Tissue Eng Part A; 2009 Sep; 15(9):2325-34. PubMed ID: 19231937
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Mechanism of Highly Active Umbilical Cord Mesenchymal Stem Cells in the Treatment of Osteoporosis in Rats.
Tian C; Lv G; Ye L; Zhao X; Chen M; Ye Q; Li Q; Zhao J; Zhu X; Pan X
Curr Stem Cell Res Ther; 2024 Feb; ():. PubMed ID: 38357953
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins.
Chen JY; Mou XZ; Du XC; Xiang C
Asian Pac J Trop Med; 2015 Sep; 8(9):739-46. PubMed ID: 26433660
[TBL] [Abstract][Full Text] [Related]
5. Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium.
Wang P; Liu X; Zhao L; Weir MD; Sun J; Chen W; Man Y; Xu HH
Acta Biomater; 2015 May; 18():236-48. PubMed ID: 25712391
[TBL] [Abstract][Full Text] [Related]
6. An In Vitro Comparative Study of Multisource Derived Human Mesenchymal Stem Cells for Bone Tissue Engineering.
Zhang Y; Xing Y; Jia L; Ji Y; Zhao B; Wen Y; Xu X
Stem Cells Dev; 2018 Dec; 27(23):1634-1645. PubMed ID: 30234437
[TBL] [Abstract][Full Text] [Related]
7. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Proliferation and Osteogenic Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Porous Scaffolds.
Dao TT; Nguyen CT; Vu NB; Le HT; Nguyen PD; Van Pham P
Adv Exp Med Biol; 2019; 1084():207-220. PubMed ID: 31214911
[TBL] [Abstract][Full Text] [Related]
9. A Calvarial Defect Model to Investigate the Osteogenic Potential of Umbilical Cord Stem Cells in Bone Regeneration.
Stanton E; Feng J; Kondra K; Sanchez J; Jimenez C; Brown KS; Skiles ML; Urata MM; Chai Y; Hammoudeh JA
Plast Reconstr Surg; 2024 Mar; 153(3):637-646. PubMed ID: 37224290
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord.
Marupanthorn K; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Manochantr S
Int J Mol Med; 2017 Mar; 39(3):654-662. PubMed ID: 28204808
[TBL] [Abstract][Full Text] [Related]
11. Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bone marrow mesenchymal stem cells in beta-tricalcium phosphate scaffolds.
Ye X; Yin X; Yang D; Tan J; Liu G
Tissue Eng Part C Methods; 2012 Jul; 18(7):545-56. PubMed ID: 22250840
[TBL] [Abstract][Full Text] [Related]
12. Impaired Bone Regenerative Effect of Exosomes Derived from Bone Marrow Mesenchymal Stem Cells in Type 1 Diabetes.
Zhu Y; Jia Y; Wang Y; Xu J; Chai Y
Stem Cells Transl Med; 2019 Jun; 8(6):593-605. PubMed ID: 30806487
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue.
Vidal MA; Walker NJ; Napoli E; Borjesson DL
Stem Cells Dev; 2012 Jan; 21(2):273-83. PubMed ID: 21410356
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of mesenchymal stromal cells from umbilical cord and amniotic membrane in xeno-free conditions.
Mu Y; Wu X; Hao Z
BMC Cell Biol; 2018 Dec; 19(1):27. PubMed ID: 30545286
[TBL] [Abstract][Full Text] [Related]
15. Cajanine promotes osteogenic differentiation and proliferation of human bone marrow mesenchymal stem cells.
Zhao ZY; Yang L; Mu X; Xu L; Yu X; Jiao Y; Zhang X; Fu L
Adv Clin Exp Med; 2019 Jan; 28(1):45-50. PubMed ID: 30141283
[TBL] [Abstract][Full Text] [Related]
16. Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison.
Mohamed-Ahmed S; Fristad I; Lie SA; Suliman S; Mustafa K; Vindenes H; Idris SB
Stem Cell Res Ther; 2018 Jun; 9(1):168. PubMed ID: 29921311
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biological characteristics of mesenchymal stem cells derived from the human umbilical cord and decidua parietalis.
Guan YT; Xie Y; Li DS; Zhu YY; Zhang XL; Feng YL; Chen YP; Xu LJ; Liao PF; Wang G
Mol Med Rep; 2019 Jul; 20(1):633-639. PubMed ID: 31180542
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.
Du WJ; Chi Y; Yang ZX; Li ZJ; Cui JJ; Song BQ; Li X; Yang SG; Han ZB; Han ZC
Stem Cell Res Ther; 2016 Nov; 7(1):163. PubMed ID: 27832825
[TBL] [Abstract][Full Text] [Related]
19. PG2, a botanically derived drug extracted from Astragalus membranaceus, promotes proliferation and immunosuppression of umbilical cord-derived mesenchymal stem cells.
Chao YH; Wu KH; Lin CW; Yang SF; Chao WR; Peng CT; Wu HP
J Ethnopharmacol; 2017 Jul; 207():184-191. PubMed ID: 28648928
[TBL] [Abstract][Full Text] [Related]
20. Wnt10b-overexpressing umbilical cord mesenchymal stem cells promote critical size rat calvarial defect healing by enhanced osteogenesis and VEGF-mediated angiogenesis.
Liu Y; Fang J; Zhang Q; Zhang X; Cao Y; Chen W; Shao Z; Yang S; Wu D; Hung M; Zhang Y; Tong W; Tian H
J Orthop Translat; 2020 Jul; 23():29-37. PubMed ID: 32477867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
